Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

June 30, 2016

Conditions
Arthritis, Rheumatoid
Interventions
BIOLOGICAL

etanercept

50mg subcutaneous, once weekly, 24 weeks

Trial Locations (31)

1036

Qualiclinic Kft., Budapest

1431

"DCC Aleksandrovska EOOD", Sofia

1612

"UMHAT Sv. Ivan Rilski EAD, Sofia", Sofia

2143

Pest Megyei Flor Ferenc Korhaz, Kistarcsa

2193

Wits Clinical Research CMJAH Clinical Trial Site, Parktown

4000

MHAT Plovdiv, Plovdiv

4001

St. Augustines Hospital, Durban/Berea

4400

Szabolcs-Szatmar-Bereg megyei, Nyíregyháza

6000

"Medical Center - New rehabilitation center EOOD", Stara Zagora

7500

Panorama Medical Centre, Panorama

10000

Medicinski Centar Kuna Peric, Zagreb

11000

Institute of Rheumatology, Belgrade

14059

Schlosspark-Klinik, Innere Medizin II, Rheumatologie, Berlin

26500

Rheumatology Department, Rion Patras

30625

Medizinische Hochschule Hannover, Hanover

39245

Immunologisches Zentrum Vogelsang-Gommern GmbH, Vogelsang-Gommern

40882

Rheumaforschung - Studienambulanz Dr. Wassenberg, Ratingen

51000

Chc Rijeka, Rijeka

56429

Rheumatology Unit, Thessaloniki

60528

Centrum für innovative Diagnostik und Therapie, Frankfurt am Main

71110

University Hospital of Heraklion, Heraklion

31-501

Krakowskie Centrum Medyczne sp. Z.O.O, Krakow

05-830

NZOZ Lecznica MAK-MED s.c., Nadarzyn

61-397

Prywatna Praktyka Lekarska Prof. UM dr hab.med. Pawel Hrycaj, Poznan

02-691

Reumatika-Centrum Reumatologii, Warsaw

841 04

Reumatologicka ambulancia, Bratislava

929 01

AAGS, s.r.o., Dunajská Streda

058 01

Reumatologicka ambulancia, MUDr. Zuzana Cizmarikova, s.r.o., Poprad

979 01

REUMEX s.r.o., Rimavská Sobota

917 01

REUMA-GLOBAL s.r.o., Trnava

010 01

Reumatologicka ambulancia, Žilina

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02378506 - Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects | Biotech Hunter | Biotech Hunter